Epigenetics Biomarkers

Epigenetic biomarkers are trending as tools for the screening and early detection of assorted diseases, for prognostic and treatment observance, and for predicting future risk of infection development. Profound changes within the epigenetic landscape of cancer cells underlie the event of human malignancies. These changes embrace large-scale deoxyribonucleic acid methylation changes throughout the genome in addition as alterations within the compendium of post-translational body substance modifications. Epigenetic aberrations impact multiple steps throughout tumorigenesis, ultimately promoting the choice of growth cells with increasing pathogenic.

  • Personalized Epigenetic Maps
  • Cardiovascular diseases

Related Conference of Epigenetics Biomarkers

July 08-08, 2022

9th World Congress on Human Genetics and Genetic Diseases

Singapore City, Singapore
July 11-12, 2022

26th Global Congress on Biotechnology

Vienna, Austria
August 25-25, 2022

7th International Conference on Molecular Medicine and Diagnostics

Singapore City, Singapore
September 19-20, 2022

International Summit on Genomics and Proteomics

Dublin, Ireland
September 19-20, 2022

15th World Congress on Stem Cell Research

Dublin, Ireland
October 17-18, 2022

21st International Conference on Structural Biology

Barcelona, Spain
November 21-22, 2022

4th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada

Epigenetics Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in